HEMOCHROMATOSIS, TYPE 3
|
1.000 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
HEMOCHROMATOSIS, TYPE 3
|
1.000 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
|
|
|
HEMOCHROMATOSIS, TYPE 3
|
1.000 |
Biomarker
|
disease |
CTD_human |
|
|
|
HEMOCHROMATOSIS, TYPE 3
|
1.000 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
|
|
|
Hereditary hemochromatosis
|
0.500 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
Anemia
|
0.130 |
Biomarker
|
disease |
HPO |
|
|
|
Amenorrhea
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Arthritis
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Fatigue
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Lymphopenia
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Neutropenia
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Purpura
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Serum iron raised
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Hyperpigmentation
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Increased serum ferritin
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Erectile dysfunction
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Hypogonadotropic hypogonadism
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Cardiomyopathies
|
0.100 |
Biomarker
|
group |
HPO |
|
|
|
Cirrhosis
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Elevated hepatic transaminase
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Hereditary hemochromatosis
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
25, 14-15, 2000) identified a stop mutation (exon 6 nt 750 C --> T, Y250X) on the transferrin receptor-2 (TFR2) gene in two unrelated Sicilian families with hereditary hemochromatosis.
|
11358390 |
2001 |
HEMOCHROMATOSIS, TYPE 3
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
Haemochromatosis type 3 is linked to a locus on 7q22 and is due to mutations in the transferrin receptor 2.
|
12401307 |
2002 |
Hereditary hemochromatosis
|
0.500 |
Biomarker
|
disease |
BEFREE |
Hereditary hemochromatosis and transferrin receptor 2.
|
21864651 |
2012 |
Hereditary hemochromatosis
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Hereditary hemochromatosis (HH) is a group of inherited iron-overload disorders associated with pathogenic defects in the genes encoding hemochromatosis (HFE), hemojuvelin (HJV/HFE2), hepcidin (HAMP), transferrin receptor 2 (TfR2), and ferroportin (FPN1/SLC40A1) proteins, and the clinical features are well described.
|
27896572 |
2017 |
Hereditary hemochromatosis
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Hereditary Hemochromatosis (HH) is a genetically heterogeneous disorder caused by mutations in at least five different genes (HFE, HJV, TFR2, SLC40A1, HAMP) involved in the production or activity of the liver hormone hepcidin, a key regulator of systemic iron homeostasis.
|
28335084 |
2017 |